structure of Adenosine 5'-monophosphate CAS 61-19-8Custom Synthesis of Nucleotides Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

61-19-8

Name

Adeno­sine 5′-monophosphate

Syn­onyms

Adeno­sine monophos­phate [Wiki] [(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydro-2-furanyl]methyl dihy­dro­gen phos­phate 200-500-0 [EINECS] 5′-Adenylic acid [ACD/​Index Name] [ACD/IUPAC Name] 5′-AMP 9-(5-O-Phosphono-β-D-ribofuranosyl)-9H-purin-6-amin [Ger­man] a-5mp acide 5′-adenylique [French] Adenosin5′-(dihydrogenphosphat) [Ger­man] [ACD/IUPAC Name] adeno­sine 5′-monophosphate Adeno­sine 5′-monophosphate Adeno­sine 5′-phosphoric acid adeno­sine phos­phate [BAN] [INN] [USAN] Adénosine-5′-(dihydrogène phos­phate) [French] [ACD/IUPAC Name] adenosine-5′-monophosphate Adenosine-5′-monophosphate ADENO­SINE-5′-MONOPHOS­PHOR­IC ACID Adenosine-5′-phosphoric Acid adenosi­ni phos­phas [Latin] AMP fos­fa­to de adenosi­na [Span­ish] [INN] t-Adenylic Acid 5′-adenylate Adeno­sine 5′-phosphorate Adenosine-5′-monophosphorate Ade­no­­sine-5-monophos­pho­r­ate Mus­cle adeny­late (S)-1-C-(7-Amino-1H-pyrazolo(4,3-d)pyrimidin-3-yl)-1,4-anhydro-D-ribitol, 5-(dihydrogen phos­phate) [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxyphosphonic acid [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihy­dro­gen phos­phate [(3S,2R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihy­dro­gen phos­phate {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid 124-68-5 [RN] 24937-83-5 [RN] 5?-Adenylic Acid 5′-Adenylic acid 54612 [Beil­stein] 5′-Adenosine monophos­phate 5′-Adenylic acid, 8-amino- 5′-AMP ​“14,158” 12352005 5′-O-phosphonoadenosine 61-19-8 [RN] 9H-purin-6-amine, 9-(5-O-phosphono-β-D-ribofuranosyl)- A5MP A-5′-P Adenosin-5-monophos­phate ADENO­SINE 3′(+2′)-MONOPHOSPHORIC ACID MONO­HY­DRATE BIO­CHEMI­KA 96% Adeno­sine 5′-monophosphate adeno­sine 5′-(dihydrogen phos­phate) adeno­sine 5’-monophosphate adeno­sine 5′-phosphate Adeno­sine 5-Monophos­phate Adeno­sine 5′-monophosphoric acid ADENO­SINE 5′-PHOSPHATE adeno­sine 5prime-monophos­phate Adeno­sine, mono(dihydrogen phos­phate) (ester) adenosine-5′-phosphate adenosine5′-monophosphate Ade­no­­sine-5-monophos­phor­ic acid adenosine-5’P Ade­no­­sine-5-phos­phate ADENO­SINE-5′-PHOS­PHATE ade­no­­sine-monophos­phate ade­no­­sine-phos­phate Ade­n­ovite Adenyl Adeny­late Adenylic acid Adenylic acid (VAN) Ado5’P AHI AMP (nucleotide) AMP (VAN) ANP ASMP ATS Car­diomone DESCAR­BOXY-NOR-N(ω)-HYDROXY-L-ARGININE Ergadenylic acid Formycin 5′-phosphate Lycedan MFCD00005750 [MDL num­ber] MFCD00149360 [MDL num­ber] Monophos­phade­nine Mus­cle adenylic acid Muske­ladenosin-phos­pho­r­saeure Muske­ladenyl­saeure My-B-Den My-B-Den (trade name) Myos­ton OR-3757 P5P pA PAdo Phosaden Phos­phaden phos­phate d’adenosine [French] [INN] Phosphen­ta­side Phos­phor­ic acid mono-[(2R,3S,4R,5R)-5-(6-amino-purin-9-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester Purine Riboside-5′-Monophosphate Vit­a­min B8

Mol­e­c­u­lar Structure

structure of Adenosine 5and#039;-monophosphate CAS 61-19-8

struc­ture of Adeno­sine 5′-monophosphate CAS 61-19-8

SMILES

c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N

Std­InChI

InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1

Std­InChIKey

UDM­BC­SSLTH­H­NCD-KQYNXXCUSA-N

Mol­e­c­u­lar Formula

C10H14N5O7P

Mol­e­c­u­lar Weight

347.22

EINECS

200-500-0

Beil­stein Reg­istry Number

54612

MDL Number

MFCD00149360

Prop­er­ties

Appear­ance

White to off-White pow­der or crys­talline pow­der

Safe­ty Data

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Adeno­sine 5′-monophosphate CAS 61-19-8

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC

Puri­ty

98% min

pH

2.5-3.5

Trans­mis­siv­i­ty of solution

≥97%

Arsenic

≤0.00015%

Con­tents

≥98%

Heavy Met­als

≤0.001%

Loss on Drying

6.0% max

Stor­age

Pre­serve in tight containers,in a cool and dry place

Appli­ca­tion

1. This prod­uct is Clin­i­cal­ly used for dis­sem­i­nat­ed scle­ro­sis, por­phyr­ia, itch­ing, liv­er dis­ease, vari­cose ulcer com­pli­ca­tions. The eye drops con­tain­ing main­ly AMP can be used for the corneal sur­face dis­eases of asthenopia,central retini­tis, pan­nus and her­pes. 2. This prod­uct can be used as nutri­tion enhancer. It can be added to the milk to increase the amount of nucleotides ,make them clos­er to human milk ingre­di­ents ,so as to enhance infant’s resis­tance against bac­te­r­i­al dis­eases. 3. This prod­uct can be used as bio­chem­i­cal reagent and inter­me­di­ate for the pro­duc­tion nucleotide drugs. And it can be used for the pro­duc­tion of Vidara­bine,ATP,cAMP, coen­zyme A, coen­zyme I, etc..

Links

This prod­uct is devel­oped by our RandD com­pa­ny Ulcho Bio­chem­i­cal Ltd(http://​www​.ulcho​.com/), and here is the cor­re­spond­ing linkhttp://​ulcho​.com/​a​d​e​n​o​s​i​n​e​-​5​-​m​o​n​o​p​h​o​s​p​h​a​t​e​-​c​a​s​-​6​1​-​1​9​-8/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the key.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.